Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.
Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.
At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.
We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.
For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.
Latest News:
- --- Source: Alphatec Holdings, Inc.
- ---
- ---
- Source: Spineology Inc.
- ---
- ---
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced participation in the North American Spine Society's Annual Meeting from September 29 to October 1, 2021. The event will highlight the company’s innovative spine solutions, including the Prone TransPsoas (PTP) technique and EOS imaging technology. ATEC aims to demonstrate the clinical utility of these advancements through presentations by leading spine surgeons at booth #2308. CEO Pat Miles emphasized ATEC's commitment to revolutionizing spine surgery.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced that Pat Miles, Chairman and CEO, and Todd Koning, CFO, will participate in two investor conferences. The first is the H.C. Wainwright 23rd Annual Global Investment Conference, featuring a virtual presentation available from September 13-15, 2021. The second is The Cantor Virtual Global Healthcare Conference on September 27, 2021, at 4:40 pm ET. Webcasts and presentation copies will be accessible on the company's investor relations website for 90 days.
ATEC aims to transform spine surgery with its innovative solutions.
Alphatec Holdings, Inc. (Nasdaq: ATEC) has priced a private offering of $275 million in 0.75% convertible senior notes due 2026, increased from a previous $250 million. The notes will settle on August 10, 2021, and yield semi-annual interest. Notably, the initial conversion price represents a premium of 32.5% over recent stock prices. Proceeds will fund capped call transactions, share repurchases of $25 million, and debt repayment. Alphatec’s financial maneuvers aim to minimize stock dilution and enhance shareholder value, although market conditions pose inherent risks.
Alphatec Holdings, Inc. (Nasdaq: ATEC) has announced a private offering of $250 million in convertible senior notes due 2026. The offering may include an additional $37.5 million, subject to market conditions. The notes will accrue interest and can be converted into common stock under certain conditions. Proceeds will be used for capped call transactions, share repurchases worth up to $25 million, and repaying loans totaling approximately $53.4 million. The notes will not be registered under securities laws and are offered only to qualified institutional buyers.
Alphatec Holdings, Inc. (ATEC) reported Q2 2021 financial results, revealing total revenues of $62.2 million and a GAAP gross margin of 66.0%. Operating expenses reached $76.8 million, resulting in a GAAP operating loss of $(35.8 million). Notably, 84% of revenue stemmed from new products, up from 61% in Q2 2020. The company forecasts $238 million in total revenue for the fiscal year, a 64% increase year-over-year. The recent acquisition of EOS imaging aims to enhance ATEC's clinical capabilities.
Alphatec Holdings, Inc. (ATEC), a leader in innovative spine surgery solutions, announced their participation in several investor conferences. Key events include:
- Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 2:30 pm ET
- UBS Genomics 2.0 and MedTech Innovations Summit on August 12, 2021, at 3:00 pm ET
- 6th Annual Needham Virtual MedTech Conference on August 16, 2021
- Piper Sandler MedTech and Diagnostics California Bus Tour on August 25, 2021
Webcasts of these presentations will be available on ATEC's Investor Relations page for 90 days.
Alphatec Holdings, Inc. (ATEC) announced the appointment of Beth Altman as an independent director and Chair of the Audit Committee, effective August 12, 2021. Altman, previously Managing Partner at KPMG LLP San Diego, brings extensive expertise in life sciences and technology. The company also shared the resignation of Donald A. Williams from the Board, effective August 11, 2021. Pat Miles, Chairman and CEO, emphasized Altman's significance in ATEC's transformation into a leading spine company.
Alphatec Holdings, Inc. (ATEC) reported strong preliminary revenue growth for Q2 2021. U.S. organic revenue is projected between $55.4 million and $56.0 million, representing a growth of 92.1% to 94.2% year-over-year. Total revenue, excluding EOS imaging, is expected to range from $55.8 million to $56.4 million, showing growth of 88.2% to 90.2%. The company anticipates full-year 2021 organic revenue growth to exceed 50%. Alphatec's cash position stands at $74.0 million as of June 30, 2021, bolstered by $40.0 million in available borrowings.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced the appointment of Marie Meynadier, Ph.D., as an independent director on its board. Dr. Meynadier, with over 25 years of experience in high tech and medical devices, previously founded EOS imaging and served as its CEO until 2018. Her expertise is expected to enhance ATEC's integration of EOS imaging technologies and support the company's strategy for international expansion. The announcement indicates a strategic move to leverage her imaging expertise as ATEC strives to establish new standards in spine surgery.
Alphatec Holdings (Nasdaq: ATEC) announced the acquisition of EOS imaging, enhancing its capabilities in spine surgery. This combination aims to improve patient outcomes through better surgical information and planning. The ATEC Informed by EOS™ initiative promises to provide actionable data that aligns with preoperative plans, significantly impacting alignment objectives and long-term clinical outcomes. EOS technology introduces advanced imaging and diagnostic capabilities, while ATEC's solutions will integrate with EOS’s platform to deliver customized surgical interventions.
FAQ
What is the current stock price of Alphatec Holdings (ATEC)?
What is the market cap of Alphatec Holdings (ATEC)?
What does Alphatec Holdings, Inc. specialize in?
What are some of the key technologies developed by Alphatec Spine?
How does Alphatec Holdings, Inc. improve spine surgery procedures?
What is the mission of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. drive growth?
Where can I find more information about Alphatec Holdings, Inc.?
What recent achievements has Alphatec Holdings, Inc. made?
What are the main products of Alphatec Holdings, Inc.?
How does Alphatec Holdings, Inc. ensure superior patient outcomes?
Is Alphatec Holdings, Inc. involved in any partnerships?
